Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2022-03-16 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司关于2021年股票期权预留授予登记完成的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Pumen Technology Co., Ltd. regarding the completion of the registration of reserved stock option grants for 2021. It details the number of stock options granted, the recipients, the source of shares, the terms of the stock option plan, performance assessment criteria, and the impact on the company's financials. The document is a formal disclosure about stock option grants and their registration, including regulatory compliance and approvals. It is not a full financial report, earnings release, or management discussion, but rather a specific announcement about stock option grants and related corporate actions. This fits the category of Capital/Financing Update (CAP), as it relates to company financing activities through stock option grants and share issuance to employees.
2022-03-16 Chinese
深圳普门科技股份有限公司2021年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2021年度业绩快报公告" which translates to "2021 Annual Performance Express Report Announcement." It contains preliminary financial data for the year 2021, including revenue, profit, and earnings per share, but explicitly states that the data is unaudited and preliminary, with final audited data to be disclosed in the formal annual report. The document is relatively short (1873 characters) and serves as a quick earnings update rather than a full annual report. It does not contain comprehensive financial statements or detailed analysis typical of a full Annual Report (10-K). Therefore, this document fits the definition of an Earnings Release (ER), which is an initial announcement of periodical financial results with key highlights only. FY 2021
2022-02-25 Chinese
深圳普门科技股份有限公司关于控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shenzhen Pumen Technology Co., Ltd. regarding its controlling subsidiary obtaining a medical device registration certificate issued by the Chongqing Drug Administration. It details the certificate specifics, product information, and the impact on the company. The document is short (849 characters) and is an announcement of a regulatory approval related to product registration, not a financial report or management discussion. It does not contain financial data, earnings, or management changes. It is a regulatory announcement about product certification, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like earnings, capital updates, or management changes.
2022-02-14 Chinese
深圳普门科技股份有限公司监事会关于公司2021年股票期权激励计划预留授予激励对象名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board opinion on the reserved grant list of incentive targets under the company's 2021 stock option incentive plan. It references compliance with company law, securities law, stock exchange listing rules, and internal company articles. The document is a formal verification and approval statement by the supervisory board regarding the stock option incentive plan participants and grant details. It does not contain financial statements, earnings data, or detailed financial analysis. It is not an announcement of voting results, nor a management or audit report. It is a regulatory compliance and supervisory opinion related to stock option incentives, which does not fit into categories like Annual Report, Earnings Release, or Capital Update. Given the nature of the document as a formal regulatory compliance opinion, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document length is short (1179 characters), and it is not a report publication announcement. Therefore, the classification is RNS with high confidence.
2022-01-24 Chinese
深圳普门科技股份有限公司2021年股票期权激励计划预留授予激励对象名单
Remuneration Information Classification · 95% confidence The document is a list of reserved stock option incentive recipients under a 2021 stock option incentive plan by Shenzhen Pumen Technology Co., Ltd. It includes detailed allocation data of stock options to various categories of employees and management. The document is dated January 21, 2022, and is signed by the company's board of directors. There is no indication that this is a full financial report, audit, or earnings release. It is not a notice of dividend, capital change, or share transaction. The content focuses on stock option incentive plan details, which is typically related to remuneration or compensation information. Given the nature of the document, it fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation plans and stock-based incentives for executives and employees.
2022-01-24 Chinese
深圳普门科技股份有限公司独立董事对第二届董事会第十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the company's stock option incentive plan, specifically about the grant of reserved stock options. It references compliance with company law, securities law, stock incentive management measures, and company articles. The document is a formal opinion related to board meeting matters but does not contain financial statements or detailed financial results. It is not a full annual or interim report, nor an earnings release. It is not a regulatory filing or certification letter. The content is focused on board/management information related to stock option grants and governance matters. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on a specific board matter, supporting this classification with high confidence.
2022-01-24 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.